MiR-145 is downregulated in human ovarian cancer and modulates cell growth and invasion by targeting p70S6K1 and MUC1

Wu Huijuan(Tianjin Medical University Cancer Institute and Hospital), Quan Hao(Gynecologic Oncology Group), Wenxin Liu(Jiujiang University), Ke Wang(Tianjin Medical University Cancer Institute and Hospital), ZhengHua Xiao(Chongqing Medical University)
Biochemical and Biophysical Research Communications
October 21, 2013
Cited by 84


Related Papers